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Malcolm Prowle scans the
costs of medical imaging
activities at four NHS
trusts and identifies what
lessons can be learnt
Feature
RADIATION VIBES
COSTING IS BACK on the NHS agenda. Its
importance has been growing in England
since national average healthcare resource
group costs were identified as the basis for
the national tariff. But there is a growing
view that understanding the costs of different
activities is vital to managing and improving
healthcare. And if costing information is to
be used to make decisions about services, it
must be accurate – NHS managers need to
understand the potential different causes for
any apparent variations in cost. 
A recent project set out to examine the
costs of radiological imaging at four acute
trusts. Such data offers huge potential
benefits. Analysing procedure costs (down to
sub-procedure level) should enable trusts to:
• Undertake more targeted and sophisticated 
pricing of procedures to third parties
• Undertake cost comparisons to be made 
with other NHS and private providers
• Analyse operational processes that make 
up an imaging procedure and associated 
costs, to help develop a simulation model 
that analyses the service and cost impact of 
changes in the process. 
The project used data from the four trusts on
the activity levels, resource inputs and
associated costs of undertaking various
radiological imaging procedures. The trusts
were broadly similar and none was a
teaching hospital or a foundation trust. The
approach was essentially a bottom-up
costing approach involving several key steps.
First, discussions were held with local
clinical staff to classify the wide range of
imaging procedures into a small number of
meaningful sub-groups – bone, abdominal,
cardiac – within a main group, such as MRI,
where the level of resources required to
undertake the procedure was broadly similar.
Then for each sub-group a data collection
template was issued to the imaging
department, which was asked to give its best
estimate of the resources required to
undertake each stage in the procedure. All
data provided was subject to validation
checks. If it failed the checks, the data was
reassessed by the trust or normalised.
Importantly, for all trusts the sum of the unit
costs calculated was fully reconciled to the
total imaging department expenditure. 
There were considerable variations
between trusts in the overall unit costs of the
same imaging group (see table 1). Further
analysis also shows large variations in the
resource composition of the unit costs –
somewhat surprising given that the project
was attempting to calculate the costs of
basically similar procedures in each trust.
The results were also compared with the
relevant direct access tariffs for the year
2005/06 (see table 2). In many cases, the
unit costs suggested by this exercise were
above the tariff for direct access services.
However, it was also apparent that in some
cases the locally derived procedure groups
did not have an obvious equivalent direct
access tariff band.
For cost information to be useful there
needs to be reasonable confidence about its
accuracy. So it is important to understand
why such significant variations exist
between NHS trusts carrying out a fairly
standard set of procedures. Given that the
sum of the unit costs across all procedures
reconciled to the total expenditure of the
imaging departments, the variations cannot
be dismissed as a result of a general over- or
under-statement of costs out of line with the
total. They must be caused by other factors. 
Analysis suggested the causal factors of
cost variations could be classified as being
of three types: operational issues; accounting
and costing practices; and data issues.
OPERATIONAL ISSUES
A number of operational issues contributing
to cost variations were identified:
• Procedure mix The trusts involved
showed significant variations in the mix of
imaging procedures within a main procedure
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type of MRI investigation was undertaken
whereas in the other two a variety of MRI
investigations were undertaken.
• Practice models Different models of
imaging practice existed between trusts. The
conduct of an imaging procedure comprises
a series of largely sequential steps starting
with referral and ending with reporting
results. Although the steps were broadly
similar, there were important differences
between trusts that could influence overall
costs. Such process differences might be the
subject of a value stream analysis under a
lean systems review.
There were also staffing mix differences.
In some trusts, for some procedures there
will be a significant radiologist involvement
while in other trusts much of the work will
be done by radiographers. Given the
difference in salary between radiologists and
radiographers, this can have a significant
impact on costs. There is some published
evidence to suggest that using radiographers
instead of radiologists need not necessarily
have a negative impact on service outcomes.  
In one trust, a significant proportion of the
pathway for MRI investigations was
outsourced to a private provider with the
evaluation and reporting of results being
provided by trust radiologists. Again, this
has significant implications on the cost
structure of the procedures, although
outcomes would also need to be factored in
to any discussions.
ACCOUNTING AND COSTING 
Differences in accounting and costing
practices also contribute to variations in cost.
• Analysis of imaging department costs
Within the trusts, the staff resources and
costs of the imaging department were
attributed to the various sub-sections of the
department – MRI or CT, say. Subsequently,
the costs of the sub-sections were attributed
by the project team to individual procedures
undertaken within the sub-sections. In some
trusts, it appears that the attribution of costs
between the sub-sections was not undertaken
very accurately with a knock-on effect on the
unit costs of the different procedures. Quite
often, certain costs that should have been
attributed to smaller sub-sections, such as
CT, were left in the largest cost pool – plain
X-rays. The understatement of costs of CT
was significant, while the overstatement of
costs of X-rays was minimal.
• Hospital overhead costs The method
and accuracy of apportioning hospital
overhead costs to the imaging department
and to its sub-sections varied between trusts. 
• Equipment costs There are different
approaches to acquiring imaging equipment
which affects unit costs. In some trusts,
imaging equipment had been fully
depreciated, avoiding depreciation charges. 
DATA FACTORS
There are also a number of data issues:
• Resource estimates There were
significant variances in the accuracy of
estimates of staff time and consumable costs
per procedure provided by imaging
departments. While the procedure costs
obtained were not overstated in total, they
could have incorporated some degree of
over- or under-statement of unit costs for
individual types of procedures.
• Sample size This project was based on
data from a small number of trusts and if one
or more of them were outliers, this could
distort the overall picture.
The results of this exercise suggest there
are limitations to the usefulness of the cost
data produced for internal planning purposes
or for making cost comparisons with other
providers. It suggests actions should be
considered to improve comparability of data.
If a trust wished to compare its unit costs
with other providers, it is important to
remove the variable concerned with the mix
of procedures. This could be done by
undertaking some modelling of the mix
variables to remove variations caused by
differing procedure mix. Improvements
could also be made to the data collection
process with more staff training and more
time for assessments to be made. This should
improve the accuracy and comparability of
unit costs produced.
There is clearly room for improvement on
costing practices. Limitations in the
procedures for apportioning overhead costs
have been noted. While greater central
prescription of costing practices might not be
attractive, trusts may need to revisit their
own costing practices to assess their
suitability in the light of the materiality of
the costs involved. Improvements in this area
should improve the accuracy and
comparability of the costing results. 
Professor Malcolm Prowle is visiting
professor at the Nottingham Business School
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Table1: Comparison of trusts’ imaging costs (£) 
Weighted
Trust A Trust B Trust C Trust D mean
MRI
Total cost per procedure 213.05 209.46 197.82 102.40 177.81
Numbers of procedures 2,816 6,412 1,340 4,363
CT
Total cost per procedure 54.33 79.81 101.20 76.71 78.43
Numbers of procedures 6,614 23,261 6,512 12,139
Ultrasound
Total cost per procedure 21.45 23.65 49.71 42.06 29.12
Numbers of procedures 25,034 95,616 18,568 25,708
Plain X-rays
Total cost per procedure 34.82 30.04 26.79 31.95 30.77
Numbers of procedures 84,567 315,312 70,297 139,413
Table 2: Comparison of the costing exercise with direct access tariffs
No of data Mean Range Direct access Direct access 
points cost of costs tariff band tariff 05/06
£ £ £
Bone MRI 4 184 95-209 F1 227
Abdominal MRI 2 139 103-234 F1 227
Cardiac MRI 2 209 201-250 No clear band No tariff
CT group 1 4 70 48-76 C5 50
CT group 2 4 92 60-116 C5 50
CT group 3 4 105 66-161 No clear band No tariff
CT group 4 4 76 59-87 C5 50
CT Interventional 4 135 106-161 No clear band No tariff
Ultrasound group 1 4 28 20-45 B3 33
Ultrasound group 2 4 37 26-68 B3 33
Ultras’d interventional 4 60 30-86 No clear band No tariff
Ultrasound mobiles 4 34 23-121 No clear band No tariff
Plain X-rays 4 27 25-32 A 16
Special X-rays 4 57 50-97 C6 70
Interventional X-rays 4 115 60-137 No clear band No tariff
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Having set up a system in which funds follow the patient, the focus in the English 
NHS is now on understanding the costs of individual episodes of care. Steve Brown
reports on the push for patient level costing
Costing gets personal
WHEN REFERENCE COSTS were introduced, there were big hopes
for the initiative. Here was a way of benchmarking treatment and
procedure costs between hospitals and engaging with clinicians about
an organisation’s costs. But in the vast majority of cases it simply
hasn’t happened. Instead, reference costs – often dismissed as an
average of average – made little sense to clinicians and they simply
switched off, leaving reference costs stuck in the finance department.
Reference costs’ credibility problem was not confined to the
clinical workforce. Many financial professionals were unconvinced
by their accuracy and thus their relevance as useful management
information. The Department of Health was also conscious of the
variability of data. There are plenty of stories of organisations
submitting ludicrous data – an average hip replacement costing less
than the price of the prosthesis, for instance – and the Department
quickly moved from publishing the full range of submitted costs to
just focusing on the interquartile figures (the middle 50% of costs).
While reference costs do have a role – particularly as the current
basis for setting the national tariff – they have not become the
important management information they were meant to be. Reference
costing has remained an annual exercise far removed from the day-
to-day running of health services.
But there is still an awareness that accurate costing information is
vital to driving service improvement. And with clinical engagement
key to any costing initiative’s success, it has been recognised that
costing has to be robust and in a form that clinicians can relate 
to – at the patient level.
The Department has been banging the drum for patient level
costing – or patient level information and costing systems (PLICS) –
for several months (Healthcare Finance, December 2006 page 8).
But it has formalised these calls recently in its Options for the future
of payment by results consultation paper, where it suggests that
patient-level costing – already widespread in private healthcare
companies – is an important opportunity for the NHS. And it talks
about building on the experience of early implementers ‘to inform the
evidence base for national roll-out’. 
The pragmatic way forward for patient level costing is the use of a
dedicated software system or managed service – the collection and
reporting of patient level information has to be close to automatic if it
is to be used for day-to-day management. But choosing the right
system or service is not straightforward. 
The complete focus on reference costing in England in recent years
means that patient level costing systems cannot simply be bought off
the shelf – certainly not systems with an established UK user base.
This means hospitals are left choosing from less familiar suppliers
with experience outside the UK or from suppliers rapidly developing
systems to meet the new demand.
The Department is keen to help. In the consultation paper, it
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